NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 104 filers reported holding NURIX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,596 | -21.9% | 47,404 | -0.7% | 0.00% | – |
| Q2 2023 | $476,842 | +10.9% | 47,732 | -1.4% | 0.00% | – |
| Q1 2023 | $430,094 | +156.9% | 48,434 | +217.6% | 0.00% | – |
| Q4 2022 | $167,423 | -15.9% | 15,248 | -0.2% | 0.00% | – |
| Q3 2022 | $199,000 | +18.5% | 15,278 | +14.9% | 0.00% | – |
| Q2 2022 | $168,000 | -10.2% | 13,297 | -0.4% | 0.00% | – |
| Q1 2022 | $187,000 | -51.0% | 13,349 | +1.4% | 0.00% | – |
| Q4 2021 | $382,000 | -20.4% | 13,171 | -17.8% | 0.00% | – |
| Q3 2021 | $480,000 | +34.1% | 16,024 | +18.8% | 0.00% | – |
| Q2 2021 | $358,000 | – | 13,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |